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Abstract
© The  Author(s)  2017.  T  2  -weighted  cardiovascular  magnetic  resonance  (T  2  -CMR)  of
myocardial  edema can quantify the area-at-risk (AAR) following acute myocardial  infarction
(AMI), and has been used to assess myocardial salvage by new cardioprotective therapies.
However, some of these therapies may reduce edema, leading to an underestimation of the AAR
by T 2 -CMR. Here,  we investigated arterial  spin labeling (ASL) perfusion CMR as a novel
approach to quantify the AAR following AMI. Adult B6sv129-mice were subjected to in vivo left
coronary artery ligation for 30 minutes followed by 72 hours reperfusion. T 2 -mapping was used
to quantify the edema-based AAR (% of left ventricle) following ischemic preconditioning (IPC) or
cyclosporin-A (CsA) treatment. In control animals, the AAR by T 2 -mapping corresponded to
that delineated by histology. As expected, both IPC and CsA reduced MI size. However, IPC, but
not CsA, also reduced myocardial edema leading to an underestimation of the AAR by T 2 -
mapping. In contrast, regions of reduced myocardial perfusion delineated by cardiac ASL were
able to delineate the AAR when compared to both T 2 -mapping and histology in control
animals, and were not affected by either IPC or CsA. Therefore, ASL perfusion CMR may be an
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